(1)
Rodríguez-Vélez, R.; Ortiz-Rivera, O. J.; Bower, B.; Gorowski, K.; Windemuth, A.; Villagra, D.; Kocherla, M.; Seip, R. L.; D’Agostino, D.; Vergara, C. Exposure to Non-Therapeutic INR in a High Risk Cardiovascular Patient: Potential Hazard Reduction With Genotype-Guided Warfarin (Coumadin®) Dosing. PRHSJ 2010, 29.